|

Precemtabart tocentecan Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Precem-TcT

Pipeline

Phase 3: 1

Top Sponsors

  • EMD Serono Research & Development Institute, Inc.1

Indications

  • Metastatic Colorectal Cancer1
  • Cancer1

Troy, Michigan1 trial

A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)

Profound Research LLC at Cancer and Leukemia Center

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.